SYSTEMIC LUPUS ERYTHEMATOSUS AFTER "IDIOPATHIC" THROMBOCYTOPENIC PURPURA: A REVIEW.
Authors: YALE RABINOWITZ
Journal: Annals of Internal Medicine (1960)

Article1 January 1960SYSTEMIC LUPUS ERYTHEMATOSUS AFTER "IDIOPATHIC" THROMBOCYTOPENIC PURPURA: A REVIEW.A study of systemic lupus erythematosus occurring after 78 splenectomies for "idiopathic" thrombocytopenic purpura, with a review of the pertinent literature* †YALE RABINOWITZ, M.D., WILLIAM DAMESHEK, F.A.C.P.YALE RABINOWITZ, M.D., WILLIAM DAMESHEK, F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-52-1-1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptWe have previously emphasized the close relationship between idiopathic thrombocytopenic purpura (I.T.P.) and systemic lupus erythematosus (S.L.E.), and have suggested that I.T.P. is often a prodrome of the larger syndrome. Actually, purpura has been known in systemic lupus erythematosus (hereafter designated S.L.E.) since early descriptions of the disease.28, 39, 40, 41Kaposi28was perhaps the first to remark on the association of lupus and purpura. Tumulty51and Harvey,23in their reviews of the history of S.L.E., have stressed Osler's understanding of the systemic nature of the disease, which he called "erythema exudativum multiforme," and his awareness of the occurrence of...Bibliography1. BaehrKlempererSchifrin GPA: A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis), Tr. A. Am. Physicians 50: 139, 1935. Google Scholar2. Beck NG: The role of hypersensitivity in the pathogenesis of disseminated lupus erythematosus, Am. Pract. and Digest Treat. 8: 54, 1957. MedlineGoogle Scholar3. BonninCohenHicks JAAKND (a) : Coagulation defects in a case of systemic lupus erythematosus with thrombocytopenia, Brit. J. Haematol. 2: 168, 1956. (b) Burnet, F. M., and Fenner, F.: The production of antibodies, 2nd Ed., 1949, The Macmillan Company, Melbourne, Australia. CrossrefMedlineGoogle Scholar4. CoburnMoore AFDH: The plasma proteins in disseminated lupus erythematosus, Bull. Johns Hopkins Hosp. 73: 196, 1943. Google Scholar5. CohenCadman HEF: The natural history of lupus erythematosus and its modification by cortisone and corticotropin (ACTH), Lancet 2: 305, 1953. Google Scholar6. Conley CL: Disorders of the blood in disseminated lupus erythematosus (Editorial), Am. J. Med. 13: 1, 1952. CrossrefMedlineGoogle Scholar7. Conley CL: The L.E. cell test, J. Chron. Dis. 5: 275, 1957. CrossrefMedlineGoogle Scholar8. DameshekReeves WWH: Exacerbation of lupus erythematosus following splenectomy in "idiopathic" thrombocytopenic purpura and autoimmune hemolytic anemia, Am. J. Med. 21: 560, 1956. CrossrefMedlineGoogle Scholar9. Dameshek W: Systemic lupus erythematosus: a complex auto-immune disorder, Ann. Int. Med. 48: 707, 1958. LinkGoogle Scholar10. Dubois EL: Symposium on recent advances in medicine; systemic lupus erythematosus, M. Clin. North America 36: 1111, 1952. CrossrefGoogle Scholar11. Dubois EL: Acquired hemolytic anemia as the presenting syndrome of lupus erythematosus disseminatus, Am. J. Med. 12: 197, 1952. CrossrefMedlineGoogle Scholar12. Dubois EL: The effect of the L.E. cell test on the clinical picture of systemic lupus erythematosus, Ann. Int. Med. 38: 1265, 1953. LinkGoogle Scholar13. DuboisMartel ELS: Discoid lupus erythematosus: an analysis of its systemic manifestations, Ann. Int. Med. 44: 482, 1956. LinkGoogle Scholar14. Dubois EL: Systemic lupus erythematosus: recent advances in its diagnosis and treatment, Ann. Int. Med. 45: 163, 1956. LinkGoogle Scholar15. DustanTaylorCorcoranPage HPRDACIH: Rheumatic and febrile syndrome during prolonged hydralazine treatment, J. A. M. A. 154: 23, 1954. CrossrefMedlineGoogle Scholar16. EvansTakahashiDuanePayneLiu RSKRTRCK: Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for common etiology, Arch. Int. Med. 87: 48, 1951. CrossrefGoogle Scholar17. Eversole SL: Cases of disseminated lupus erythematosus diagnosed as idiopathic thrombocytopenic purpura, Bull. Johns Hopkins Hosp. 96: 210, 1955. MedlineGoogle Scholar18. Fox RA: Disseminated lupus erythematosus—an allergic disease?, Arch. Path. 36: 311, 1943. Google Scholar19. GardnerDiamond FHLK: Autoerythrocyte sensitization, a form of purpura producing painful bruising following autosensitization to red blood cells in certain women, Blood 10: 675, 1955. CrossrefMedlineGoogle Scholar20. GoldGowing SCNF: Systemic lupus erythematosus. A clinical and pathological study, Quart. J. Med. 22: 457, 1953. MedlineGoogle Scholar21. HargravesOpfell MMRW: Systemic lupus erythematosus and the blood, in Progress in hematology, Tocantins, L. M., Editor, Vol. I, 1956, Grune & Stratton, New York, pp. 249-264. Google Scholar22. Hargraves MM: Symposium on systemic lupus erythematosus. The L.E. cell phenomenon, Proc. Staff Meet., Mayo Clin. 27: 419, 1952. MedlineGoogle Scholar23. HarveyShulmanTumultyConleySchoenrich AMLEPACLEH: Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases, Medicine 33: 291, 1954. CrossrefMedlineGoogle Scholar24. HirschDameshek EOW: "Idiopathic" thrombocytopenia; review of 89 cases with particular reference to differentiation and treatment of acute (self-limited) and chronic types, Arch. Int. Med. 88: 701, 1951. CrossrefGoogle Scholar25. JessarLamont-HaversRagan RARWC: Natural history of lupus erythematosus disseminatus, Ann. Int. Med. 38: 717, 1953. LinkGoogle Scholar26. Johnson HM: Effect of splenectomy in acute systemic lupus erythematosus, Arch. Dermat. and Syph. 68: 699, 1953. CrossrefGoogle Scholar27. Kaiser IH: The specificity of periarterial fibrosis of the spleen in disseminated lupus erythematosus, Bull. Johns Hopkins Hosp. 71: 31, 1942. Google Scholar28. Kaposi M: Neue Beitrage zur Kenntnis des Lupus erythematosus, Arch. f. Dermat. u. Syph. 4: 36, 1872. CrossrefGoogle Scholar29. Keil H: Relation between "systemic" lupus erythematosus and a peculiar form of thrombocytopenic purpura, Brit. J. Dermat. 49: 221, 1937. CrossrefGoogle Scholar30. KlempererPollackBaehr PADG: Pathology of disseminated lupus erythematosus, Arch. Path. 32: 569, 1941. Google Scholar31. KlempererGueftLeeLeuchtenbergerPollister PBSLCAW: Cytological changes of acute lupus erythematosus, Arch. Path. 49: 503, 1950. Google Scholar32. Kurnick NB: The pseudo-L.E. cell phenomenon, with report of a case, Blood 12: 382, 1957. CrossrefMedlineGoogle Scholar33. MartenBlackburn RHEK: Lupus erythematosus; clinical and hematological studies in 77 cases, Arch. Dermat. 73: 1, 1956. CrossrefGoogle Scholar34. MichaelVuralBassenSchaefer SRILFAL: The hematologic aspects of disseminated (systemic) lupus erythematosus, Blood 6: 1059, 1951. CrossrefMedlineGoogle Scholar35. MontgomeryMcCreight HWG: Disseminate lupus erythematosus, Arch. Dermat. and Syph. 60: 356, 1949. CrossrefGoogle Scholar36. MooreShulmanScott JELEJT: The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors; interim report, J. Chron. Dis. 5: 282, 1957. CrossrefMedlineGoogle Scholar37. Ogryzlo MA: The L.E. (lupus erythematosus) cell reaction, Canad. M. A. J. 75: 980, 1956. MedlineGoogle Scholar38. OgryzloSmythe MAHA: Systemic lupus erythematosus and syndromes possibly related, Pediatrics 19: 1109, 1957. CrossrefMedlineGoogle Scholar39. Osler W: On the visceral complications of erythema exudativum multiforme, Am. J. M. Sc. 110: 629, 1895. CrossrefGoogle Scholar40. Osler W: The visceral lesions of the erythema group, Brit. J. Dermat. 12: 199, 1900. Google Scholar41. Osler W: On the visceral manifestations of the erythema group of skin diseases, Tr. A. Am. Physicians 18: 599, 1903. Google Scholar42. PerrySchroeder HMHA: Syndrome simulating collagen disease caused by hydralazine (Apresoline), J. A. M. A. 154: 670, 1954. CrossrefMedlineGoogle Scholar43. Reiches AJ: The lupus erythematosus syndrome: the relationship of discoid (cutaneous) lupus erythematosus to systemic (disseminated) lupus erythematosus, Ann. Int. Med. 46: 678, 1957. LinkGoogle Scholar44. Rich AR: Cases of disseminated lupus simulating thrombocytopenic purpura, Clinical Pathological Conference, The Johns Hopkins Hospital, May 9, 1949, cited by Harvey, A. McG.23 Google Scholar45. DameshekRubioMahoneyReevesBurgin WFJPWHLA: Treatment of idiopathic thrombocytopenic purpura (I.T.P.) with prednisone, J. A. M. A. 166: 1805, 1958. CrossrefMedlineGoogle Scholar46. ShearnPirofsky MAB: Disseminated lupus erythematosus; analysis of 34 cases, Arch. Int. Med. 90: 790, 1952. CrossrefGoogle Scholar47. TalbottMoleres Ferrandis JHRM: Collagen diseases including systemic lupus erythematosus, polyarteritis, dermatomyositis, systemic scleroderma, thrombotic thrombocytopenic purpura, 1956, Grune & Stratton, New York, p. 17. Google Scholar48. Teilum G: Pathogenetic studies on lupus erythematosus disseminatus and related diseases, Acta med. Scandinav. 123: 126, 1946. CrossrefMedlineGoogle Scholar49. Teilum G: Hyperglobulinemia, periarterial fibrosis of the spleen, and the wire loop lesion in disseminated lupus erythematosus in relation to allergic pathogenesis, Am. J. Path. 24: 409, 1948. MedlineGoogle Scholar50. TumultyHarvey PAAM: The clinical course of disseminated lupus erythematosus. An evaluation of Osler's contributions, Bull. Johns Hopkins Hosp. 85: 47, 1949. Google Scholar51. Tumulty PA: The clinical course of systemic lupus erythematosus, J. A. M. A. 156: 947, 1944. CrossrefGoogle Scholar52. WalshZimmerman JRHJ: The demonstration of the "L.E." phenomenon in patients with penicillin hypersensitivity, Blood 8: 65, 1953. CrossrefMedlineGoogle Scholar53. WilsonJordan APJW: Relationship of chronic discoid and disseminated lupus erythematosus, New York J. Med. 50: 2449, 1950. MedlineGoogle Scholar54. WitebskyRose ENR: Studies on organ specificity. IV. Production of rabbit thyroid antibodies in the rabbit, J. Immunol. 76: 408, 1956. MedlineGoogle Scholar55. WitebskyRoseTerplanPaineEgan ENRKJRRW: Chronic thyroiditis and autoimmunization, J. A. M. A. 164: 1439, 1957. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Received for publication May 27, 1959.Presented in part at the Fortieth Annual Session of the American College of Physicians, Chicago, Illinois, April 22, 1959.†Aided by Grants from the U. S. Public Health Service; National Institutes of Health (Heart) Contract #H2021 and the National Institute of Arthritis and Metabolic Diseases. #A-2037.‡Studies performed under tenure of Dazian Foundation and U. S. Public Health Service postdoctoral research fellowships. Formerly Reseach Fellow in Hematology, New England Center Hospital and Tufts University School of Medicine. Current address: Veterans Administration Hospital, Brooklyn 9, N. Y.From the Blood Research Laboratory, a unit of the Ziskind Laboratories, New England Center Hospital, and the Department of Medicine, Tufts University School of Medicine.Requests for reprints should be addressed to Yale Rabinowitz, M.D., Laboratory and Research Division, Veterans Administration Hospital, 800 Poly Place, Brooklyn 9, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySystemic lupus erythematosus, following prodromal idiopathic thrombocytopenic purpura, presenting with skin lesions resembling malignant atrophic papulosisClinical Features of Systemic Lupus ErythematosusEltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosusAcute Retrobulbar Optic Neuritis with Hematologic AbnormalitiesClinical Features of Systemic Lupus ErythematosusEvans syndrome and Systemic Lupus Erythematosus: Clinical presentation and outcomeSyndrome d'Evans et lupus érythémateux systémique : présentation clinique et évolutionSplenectomy for thrombocytopenia associated with systemic lupus erythematosus in 11 Chinese patientsThe 'Connective Tissue Diseases'Thrombosis after a Splenectomy in a Patient with Systemic Lupus Erythematosus-related ThrombocytopeniaAntinuclear antibody (ANA)–positive thrombocytopenia: primary, but with a differenceSYSTEMIC LUPUS ERYTHEMATOSUSTherapeutic Approaches to Secondary Immune Thrombocytopenic PurpuraA positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpuraSystemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factorThrombocytopenic PurpuraReview of ACR hematologic criteria in systemic lupus erythematosusThrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopeniaAutoimmune ThrombocytopeniasAutoimmune thrombocytopenia in primary antiphospholipidsyndrome and systemic lupus erythematosus: The response to splenectomyClinical Significance of the Antinuclear Antibody Test in Selected Children with Idiopathic Thrombocytopenic PurpuraAutoimmune (idiopathic) thrombocytopenic purpuraAplastic anemia as the sole presentation of systemic lupus erythematosusDiagnosis, treatment and pathophysiology of autoimmune thrombocytopeniasHaematological manifestations of systemic lupus erythematosusCellular Immune Mechanisms in Chronic Autoimmune Thrombocytopenic Purpura (ATP)Thrombocytopenia in the Intensive Care Unit SettingAntinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2–30 yearsSystemic tapes erythematosus and myelofibrosis8 Autoimmune thrombocytopeniasMale lupus: Retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literatureClinical and Serologic Features: Incidence and Diagnostic ApproachIdiopathic thrombocytopenic purpura with high-titer, speckled pattern antinuclear antibodies: Possible marker for systemic lupus erythematosusHemocytopenia as initial manifestation of systemic lupus erythematosus. Prognostic significanceChronic autoimmune thrombocytopenic purpuraPlatelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: A platelet specific immunoglobulin inducing the release reactionImmunoregulatory abnormalities in children withthrombocytopenic purpuraPERIPHERAL LYMPHOCYTE SUBPOPULATIONS AND THE INFLUENCE OF SPLENECTOMY IN IDIOPATHIC PORTAL HYPERTENSIONIdiopathic Thrombocytopenic PurpuraSplenic function in non-renal systemic lupus erythematosusThrombocytopenia in a young womanPlatelet satellitism and phagocytosis by neutrophils: Association with antiplatelet antibodies and lymphomaThrombozytäres SystemHematologic Aspects of Systemic Lupus Erythematosus Current ConceptsDANIEL R. BUDMAN, M.D., ALFRED D. STEINBERG, M.D.Thrombocytopenia in Childhood: An Evaluation of 433 PatientsUncommon Connective Tissue Disorders in ChildhoodStudy of haemostasis in nephropathies associated with pulmonary haemorrhageCLINICAL DISORDERS RELATED TO BLOOD PLATELETSMilz und Morbus Werlhof�ber einen Hemmk�rper der ProthrombinaktivierungDefibrination syndrome in a patient with chronic thrombocytopenic purpuraBIBLIOGRAPHYZum Problem des Nachweises antithrombocytärer AutoantikörperThrombotic thrombocytopenic purpura in siblingsPain in the Extremities, Dysesthesia, PolyalgiaIdiopathic Thrombocytopenic PurpuraPeripheral Vascular Syndromes Associated with Systemic Lupus ErythematosusDONATO ALARCÓN-SEGOVIA, M.D., PHILIP J. OSMUNDSON, M.D., F.A.C.P.Der viscerale Lupus erythematodesIndications for splenectomy in the pediatric patientREFERENCESRheumatism and Arthritis Review of American and English Literature of Recent Years (Fifteenth Rheumatism Review)CHARLEY J. SMYTH, M.D., F.A.C.P., FELIX E. DEMARTINI, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., EDWARD C. FRANKLIN, M.D., DONALD F. HILL, M.D., F.A.C.P., JOSEPH LEE HOLLANDER, M.D., F.A.C.P., HOWARD L. HOLLEY, M.D., F.A.C.P., JOHN G. MAYNE, M.D., F.A.C.P., WILLIAM M. MIKKELSEN, M.D., F.A.C.P., MAX M. MONTGOMERY, M.D., F.A.C.P., CARL M. PEARSON, M.D., F.A.C.P., CHARLES L. SHORT, M.D., F.A.C.P., HUGH A. SMYTHE, M.D., F.R.C.P. (C), OTTO STEINBROCKER, M.D.Recurrent Acute Idiopathic Thrombocytopenic PurpuraIndikationen zur Splenektomie bei BlutkrankheitenTreatment of Chronic Idiopathic Thrombocytopenic Purpura in the AdultA Critical Look at the Splenectomy-S.L.E. ControversyThe clinical manifestations of systemic lupus erythematosusIDIOPATHIC AND SECONDARY THROMBOCYTOPENIC PURPURA: CLINICAL STUDY AND EVALUATION OF 381 CASES OVER A PERIOD OF 28 YEARS*CHARLES A. DOAN, M.D., F.A.C.P., BERTHA A. BOURONCLE, M.D., BRUCE K. WISEMAN, M.D., F.A.C.P. 1 January 1960Volume 52, Issue 1Page: 1-28KeywordsFibrosisHeart diseasesHematology and oncologyHospital medicineIdiopathic thrombocytopenic purpuraLupus erythematosusMedical servicesMetabolic disordersResearch laboratoriesSystemic lupus erythematosus ePublished: 1 December 2008 Issue Published: 1 January 1960 Copyright & PermissionsCopyright ©, 1960, by The American College of PhysiciansPDF downloadLoading ...